Oric Pharmaceuticals (ORIC)
(Delayed Data from NSDQ)
$10.48 USD
-0.34 (-3.14%)
Updated Sep 23, 2025 04:00 PM ET
After-Market: $10.48 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
D Value D Growth A Momentum D VGM
Fundamental Charts
About Cash from Investing (TTM)
The company's trailing twelve month (TTM) Cash from Investing is the sum of the company's past 12 months cash position resulting from any gains or losses from investments in the financial markets, operating activities, and changes resulting from amounts spent on investments in capital assets such as plant and equipment. When evaluating the Cash from Investing value, it is important to consider each of the various activities which contribute to the overall change in cash position. A company can have a negative cash flow from investing and have a positive cash from Cash from operations or financing.
ORIC 10.48 -0.34(-3.14%)
Will ORIC be a Portfolio Killer in September?
Zacks Investment Research is releasing its prediction for ORIC based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for ORIC
Oric Pharmaceuticals, Inc. (ORIC) Now Trades Above Golden Cross: Time to Buy?
Oric Pharmaceuticals, Inc. (ORIC) is a Great Momentum Stock: Should You Buy?
ORIC: What are Zacks experts saying now?
Zacks Private Portfolio Services
All You Need to Know About Oric Pharmaceuticals (ORIC) Rating Upgrade to Buy
Does Oric Pharmaceuticals (ORIC) Have the Potential to Rally 104.99% as Wall Street Analysts Expect?
What Makes Oric Pharmaceuticals, Inc. (ORIC) a Strong Momentum Stock: Buy Now?
Other News for ORIC
Is ORIC poised for gains? 20 Day Moving Average Support shows up after climbing 2.46%
Oric Pharmaceuticals management to meet virtually with Cantor Fitzgerald
ORIC's price falls by 4.0% on September 19, though its technical setup remains stable.
The technical outlook for ORIC is unchanged after it rises 4.56% on September 18
50 Day Moving Average Support appears for ORIC after 3.49% move